|
Volumn Suppl Web Exclusives, Issue , 2003, Pages
|
Examining the FDA's oversight of direct-to-consumer advertising.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ADVERTIZING;
CLINICAL PRACTICE;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG UTILIZATION;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LEGAL ASPECT;
NOTE;
PATIENT PARTICIPATION;
PRACTICE GUIDELINE;
RECUMBENCY;
STANDARD;
UNITED STATES;
ADVERTISING;
DECEPTION;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG UTILIZATION;
GUIDELINES;
HUMANS;
PATIENT PARTICIPATION;
PHYSICIAN'S PRACTICE PATTERNS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 1542437819
PISSN: 02782715
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (18)
|
References (0)
|